Shadd Dales and co-host Anthony Varrell, powered by Dutchie, dive into two big stories making waves right now in cannabis and psychedelics.Segment One brings on Noah Hamman, Founder & CEO of AdvisorShares and Managing Director of the AdvisorShares Pure US Cannabis ETF (NYSE Arca: MSOS). For 18 straight trading sessions, MSOS has seen inflows as investors pile into U.S. cannabis equities on the back of rescheduling momentum. Noah explains how he manages those inflows, allocates capital across top operators, and whether building up a cash position makes sense at this stage of the cycle. With cannabis rescheduling chatter intensifying, MSOS (ticker: MSOS) has become one of the most closely watched ETFs in the industry, and Hamman provides insight into what investors should know right now.Segment Two shifts to psychedelics reform. We welcome Shane Pennington, Partner at Blank Rome LLP, and widely regarded as one of the most qualified attorneys in the U.S. on cannabis and psychedelic policy. Shane breaks down the DEA’s decision to advance a petition to reschedule psilocybin, sending it to federal health officials for review. We explore what this move really means, how the process works, and what the implications are for patients, researchers, and the broader therapeutic landscape.0:00:00 IntroNoah Hamman Interview0:02:17 ETF Inflows & Allocation Strategy 0:05:00 Active Management, Liquidity, and Stock Selection 0:07:17 Capacity Challenges, Swaps, and Market Mechanics 0:10:00 ETF Creation/Redemption Process & Market Maker Roles 0:16:08 Shorting, Volume, and ETF Mechanics 0:20:00 Counterparty Risk, Swaps, and Regulatory Oversight 0:22:50 Adding New Components to the ETF 0:24:10 Cash Balance Strategy & Market Impact 0:27:00 Swaps vs. Physical Custody in the ETF 0:29:19 New Investors Post-Rescheduling 0:30:58 ETF Holdings, Balance Sheet Health, and Performance 0:34:00 ETF Inflows, Outflows, and Portfolio Adjustments 0:35:00 Closing Remarks & TransparencyShane Pennington Interview0:35:59 Capital Markets & Cannabis Industry 0:39:01 Presidential Statements & Administrative Process 0:41:00 Psychedelics Policy & DEA Petition 0:44:22 Right to Try Laws & Psilocybin 0:49:10 Rescheduling Process & Timelines 0:55:00 International Psychedelic Companies & VA Partnerships 0:58:16 Human Impact & Policy Change 0:59:38 Podcast Wrap-Up#Cannabis #Investing #ETFs #MSOS #Psychedelics #Psilocybin #Rescheduling #AdvisorShares #DEA #cannabisstocks #cannabisreform #MarijuanaRescheduling #CannabisRescheduling Want to see last week's recap? • Trump Comments Spark Cannabis Rally | TTB ... Want to see more Cannabis Reform videos? • Cannabis Debate Moves Into Mainstream Amer... • Texas Hemp Ban? Breaking Down SB 6 | TDR C... • Cannabis Stocks Reset After Options Expiry... • Texas Cannabis: Expansion or Hemp Ban? | T... • Trump Eyes Cannabis Rescheduling — Myths v... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comAll views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...
